Adar Poonawalla, CEO of Serum Institute of India, highlighted the potential of the vaccine to save lives in malaria-stricken regions of Africa and acknowledged ... Oct 04
The Centre took more than six months to put its act together on the domestic front and shortlisted three PSUs only by April 2021 for ... May 13
The supply of the third vaccine is bound to strengthen the Covid-19 vaccination drive across the country. ... Apr 13
Bangladesh has thanked India for the gift of 2 million doses of the COVID 19 vaccine sent last month ... Feb 18
... Feb 16
Serum Institute to supply the vaccines... Feb 16
As the vaccine earns approval from WHO now it is eligible for distribution in low and middle-income countries... Feb 16
Afghanistan has had 55,335 COVID-19 cases and 2,410 deaths from the disease, according to the health ministry.... Feb 09
Bangladesh rolls out nationwide vaccination program with AstraZeneca-Oxford vaccine... Feb 08
Yesterday, 18,166 healthcare workers were vaccinated at 267 centres in the state... Jan 21
Adar Poonawalla says WHO approval expected in next couple of weeks... Jan 15
All preparations for the first phase of COVID vaccination have been completed. Today, 5,63,500 doses of vaccine were received by the State. ... Jan 14
PM Narendra Modi said that government will bear the cost of 3 crore vaccination for frontline workers... Jan 12
The much-awaited distribution of the Covishield Vaccine developed by Serum Institute of India(SII) in Pune began today. Six cold storage containers with the ... Jan 12
India has signed a purchase order with vaccine producer Serum Institute to procure AstraZeneca’s COVID-19 vaccine, a source said on Monday, the first ... Jan 11
Brazilian President Jair Bolsonaro has requested India for 2 million doses of Covishield vaccine produced indigenously by the Serum Institute of India, Pune.... Jan 11
The approval to import the vaccine was granted by the Directorate General of Drug Administration (DGDA) of Bangladesh late on Monday to Beximco Pharmaceuticals Ltd. (... Jan 05
DGCI on Sunday (January 3) formally approved Serum Institute's Covishield and Bharat Biotech's Covaxin for use in India. ... Jan 04
Both the vaccines are cleared by DCGI... Jan 04
Pneumosil is an example of India's capability in Research and Development and manufacturing high end sophisticated Vaccines... Dec 29
Serum Institute Of India And Dynavax, today jointly announced that the first participants have been dosed in the Phase 1 part of the Phase 1/... Dec 24
At the vaccination site, only pre-registered beneficiaries will be vaccinated in accordance with the prioritization... Dec 15
Bangladesh government is also in talks with other countries to procure more doses of the COVID-19 vaccine... Dec 14
Bharat Biotech, developer of indigenous COVID-19 vaccine, COVAXIN has applied to the central drug regulator, DCGI, seeking emergency use authorization for its vaccine.... Dec 08
Serum Institute of India (SII) in Pune has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford-AstraZeneca ... Dec 07
-Advertisements-
-23-300x250.png)
.jpeg)
Thursday, October 29, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
